Oslo University Hospital
Oslo, 0471, Norway
NCT Number: NCT01845233
The purpose of this study is to determine whether clinical examination, report from ventilator software, nocturnal Sp02 and daytime arterial blood gas are sufficient as screening tools to reveal clinical relevant problems with patients receiving long term treatment with non invasive ventilation.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Oslo, 0471, Norway
Patient with chronic hypoventilation with stable on long term treatment (LTMV) with non-invasive ventilation for at least 3 month taking part of our LTMV program will be included.
In addition to clinical examination,report from ventilator software, nocturnal Sp02 and daytime arterial blood gas all patients will be investigated with sleep polygraphy and transcutaneous Co2.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Exclusion criteria
Time frame: single night study
Time frame: Single night study
Time frame: One night study
Time frame: one night study
Time frame: Single night study
Time frame: single night study
Time frame: single night study
Oslo University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06142513
Apnea, Body Weight
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05398068
Anxiety Disorders, Apnea
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05949164
Apnea, Central Sleep Apnea
Toronto, Ontario, Canada
View Trial DetailsNCT04322994
Anesthesia; Adverse Effect, Desaturation of Blood
Palo Alto, California, United States
View Trial Details